Buy the full study
Summary of our market study
to understand this market
Detailed content of our market study
Inforamtion
- Number of pages : ~ 40 pages
- Format : Digital and PDF versions
- Last update :
Summary and extracts
1 Market summary
1.1 Definition and presentation
Food supplements include any type of product whose purpose is to supplement one's diet by providing necessary and additional nutrients. According to the European directive - 2002/46/EC - supplements are defined as "food products that are in the form of capsules, tablets, pills and the like."
Among the most popular categories:
- Vitamins, such as D and E
- Minerals, such as calcium and iron
- Specialty products, such as probiotics and glucosamine
Dietary supplements indeed have attributes that can relate the product to nutritional and physiological benefits. They are not identified with pharmaceuticals because their positive impact on the body and mind does not act as therapeutic [ Chamber of Commerce ].
Dietary supplements have shown tremendous growth worldwide, primarily leveraging consumers' progressive focus on health and the global increase in the elderly population.
Western Europe is among the top performers in the sector, with Italy leading the way, counting double-digit value growth from 2009 to 2019, attributable primarily to changing demographics, consumer health awareness, and the availability of nutritional information
Italy is the largest market in Europe and one of the largest in the world, with the aging population being an important driver of this market. During the COVID-19 pandemic, individuals began to pay more attention to their personal health and had more time to rebalance and calibrate their diets, leading to exponential growth in some segments of this market.
1.2 A well-focused global market with good growth prospects
The global market for dietary supplements has been estimated at $***.* billion in ****.
The most optimistic forecasts predict a CAGR (***) of *.*% between **** and **** with the market expected to generate about $***.* billion globally by ****.
Size of the global market for dietary supplements World, ****-*****, in billions of dollars Source: ****
Growing awareness of the ...
1.3 The Italian market, a European leader
Western Europe is the third largest region within the dietary supplement market, after Asia and North America. However, the largest share lies exclusively in the hands of three players: Italy boasts the largest dietary supplement market in Europe, more than a quarter of its total, with expectations of close to * billion ...
1.4 Imports and exports
Using the UN Comtrade database, it is complicated to study dietary supplements as a whole because this segment includes a wide variety of products classified under different customs codes. However, it is possible to analyze a part of it and observe, for example, the trade in vitamins and provitamins that make ...
1.5 Impact of Russian-Ukrainian conflict
The outbreak of the Russian-Ukrainian conflict in February **** led to, among other things, a general increase in the producer price index. This increase also affected the dietary supplements sector. Through analysis of the producer price index for the other food products sector (***), within which dietary supplements fall, an increase of ** points ...
2 Demand analysis
2.1 Overview of demand
Dietary supplements are substances recommended to accompany one's diet, so they are not specifically identified with either food or medicine. Demand for these product categories is therefore related to personal understanding or available information (***) of the associated effects and one's weight in a balanced diet.
The main factors positively influencing the ...
2.2 Lifestyle and new habits change consumption
Increased stress levels
Dietary supplement intake is closely related to perceived and actual health and well-being. Therefore, the progressively higher proportion of stressed Italians may play an important role in shifting demand. The number of males who reported being stressed is extremely high, * out of **, according to research conducted by ASSOSALUTE ...
2.3 The consumption habits of Italians
**% of the Italian adult population (***) use food and dietary supplements[***]. The reasons for their use can be divided into * major categories:
Prevention (***) Wellness (***) Toning, strengthening and energy (***) Specific care (***)
Use of dietary supplements, by reason Italy, ****, in % Source: ****
In Italy, nearly two-thirds of consumers of dietary supplements consider them safe, while ...
2.4 Why to use dietary supplements
Regarding the reasons for the purchase and use of dietary supplements, nearly * out of * Italians say that supplements are excellent allies of health; the same proportion claims that supplements are a stimulus for dietary improvement and increased physical activity. Finally, * out of * Italians consider dietary supplements functional for maintaining mental and ...
2.5 New trends in demand
The growth of the sports segment
The sports nutrition supplement market is a segment of the dietary supplement market, but also a segment of the sports nutrition market. The latter has particularly developed in recent years, driven by the democratization of dietary supplements, which were previously consumed mainly by professional ...
3 Market structure
3.1 Market organization and dynamics
Until the beginning of the **st century, the dietary supplement market had a well-defined structure. The largest share was in the hands of a few international players - e.g. Pfizer, Bayer, Sanofi - although a considerable part was held by Italian manufacturers - e.g. Aboca, Alfasigma. Recently, radical transformations ...
3.2 Made-in-Italy production
CDMO (***) is a business organizational model, which enables the management of production, development and manufacturing activities of medical products on behalf of third parties.
Thus, we distinguish:
Companies authorized to distribute pharmaceutical products-usually multinational pharmaceutical companies, which outsource functions to CDMO companies. Companies that follow CDMOs to produce and manufacture pharmaceutical ...
3.3 Distribution
Despite the increasing proliferation of distribution channels, leadership seems to remain in the hands of health and beauty specialty retailers-for example, pharmacies. The latter continue to account for an extremely large market share of about **.*%[***].
Supplement market breakdown Italy, ****, percent Source: ****
business to Business
Production and manufacturing take place in another ...
3.4 The dominance of pharmacies
As we saw above, pharmacies hold the absolute majority in terms of distribution in this market, both in terms of value and volume.
However, it is interesting to look at a deeper and more detailed breakdown of this market by segment (***) Pharmacies hold a majority share in terms of value for ...
3.5 Value chain and production
Source: ****
First, ingredient suppliers produce the raw materials, that is, the nutrients, but also the flavorings or colorings that will make up the dietary supplements.
Manufacturers use these ingredients to make dietary supplements. There are two types of manufacturers: processors who supply the supplements to different companies that will market them, ...
4 Supply analysis
4.1 A number of product categories
One variable that can be considered when segmenting the dietary supplement market is product function.
According to Unife there are five categories that can be identified by product function:
Sports Health and wellness Diet Anti-aging Beauty care
A further distinction available concerns the ingredients contained in dietary supplements. Among the most ...
4.2 Supply trends
Personalized nutrition
More and more companies are moving away from the concept of "one size fits all" to improve the customer experience through highly personalized offerings. In the health sector the trend is widely visible, with many existing companies as well as innovative startups addressing this need. [***].
Some newcomers:
US-based Habit ...
4.3 Prices
Per capita spending on dietary supplements among Italians in **** reached about ** euros-the number places Italy in first place. In fact, spending is almost double the average spending in Western European countries [***].
Below are the prices of some of the products on the Italian market:
4.4 Research is at the heart of the offering
The role of innovation To stand out, many companies launch their own research programs to innovate and create new products. Thus, research involves not only ingredients, but also formulations and containers. Innovation in natural, organic and vegan products is particularly on the rise. Innovations in the dietary supplement market include the ...
5 Rules and regulations
5.1 Three levels of legislation
There are three different levels of legislative procedures to follow:
EU regulations Italian legislation Ministry of Health
There are EU regulations for vitamins, minerals and substances used as their sources. In addition, rules regarding the use of substances potentially harmful to consumers' health are also harmonized at the EU level.
According ...
6 Positioning of actors
6.1 Segmentation
- Pfizer
- Sanofi Aventis
- Bayer
- Labocast
- Biofarma
List of charts presented in this market study
- Size of the global market for dietary supplements
- Répartition du marché européen des compléments alimentaires par produit
- Vitamin consumption by type
- Breakdown of the European dietary supplement market, by market share
- Market value of dietary supplements
All our studies are available online in PDF format
Take a look at an example of our research on another market!
Latest news
Chemicals in the midst of a recovery, Bayer considers spin-offs - 09/11/2023
- Bayer sales: Close to 50 billion euros.
- Date on which Bayer will make a decision on the demerger of its entities: March 2024.
- Loss of value of the Bayer Group in five years: 40%.
- Bayer weighed down by falling glyphosate sales
Sanofi plans to spin off its Consumer Healthcare business in 2024 - 28/10/2023
- Year of separate listing of Sanofi's Consumer Healthcare Division: 2024
- Sanofi envisages savings of: up to 2 billion euros between 2024 and the end of 2025
- Presence of Sanofi Consumer Healthcare Division: 150 countries, more than 11,000 employees
Sanofi to spin off its consumer healthcare division and float it on the stock market - 27/10/2023
- Sanofi is a French pharmaceutical company
- The Consumer Healthcare division has over 11,000 employees in 150 countries.
- The demerger of Consumer Healthcare will take place in the fourth quarter of 2024 at the earliest.
- This division accounts for just over 10% of Group sales.
- In 2022, the Consumer Healthcare division generated 5.1 billion euros of Sanofi's 43 billion euros in sales.
- The Consumer Healthcare division posted growth of 13.7% in 2022.
- By 2021, the global consumer healthcare market will be worth over €180 billion.
- The market share of Haleon, the world leader in consumer healthcare, is estimated at 6% in 2021.
- The over-the-counter segment accounts for 90 billion euros, vitamins, minerals and supplements for 50 billion euros, and oral care for almost 30 billion euros.
- Its Dupixent sales approach 11 billion euros in annual sales.
- Beyfortus vaccine is currently marketed in 4 countries, including France.
Sanofi inaugurates Europe's largest vaccine plant at Val-de-Reuil - 07/09/2023
- Sanofi's vaccine plant in Val-de-Reuil celebrated its 50th anniversary.
- Sanofi has invested 250 million euros in two modernization/expansion projects at the plant, which employs 2,200 people.
- It ships 600 million doses of vaccines worldwide every year.
- Sanofi has set up a new influenza vaccine production unit, at a cost of 200 million euros.
- Over the past ten years, Sanofi has invested 600 million euros in Val-de-Reuil.
- Sanofi plans to double sales of its vaccines division between 2018 and 2030, to more than 10 billion euros a year.
Sanofi invests $250 million in flu vaccines in France | Sanofi invests $250 million in flu vaccines in France - 07/09/2023
- Sanofi is the world's fourth-largest vaccines company
- Sanofi invests 250 million euros in its Val-de-Reuil site, Europe's largest vaccine production facility
- Sanofi has 11 vaccine plants
- 50% of Sanofi's production is concentrated in influenza.
- Sanofi increases influenza vaccine production capacity by 40%
- Sanofi's Efluelda vaccine is recommended for the elderly and launched in 18 countries, including 11 where it has been recommended by health authorities.
- Sanofi has invested over 600 million euros in its Val-de-Reuil site over the past ten years.
Bayer's glyphosate sales plummet - 25/07/2023
- Full-year sales for the current financial year are forecast at between 48.5 and 49.5 billion euros.
- Bayer acquired the US group Monsanto in 2018 for over 63 billion euros.
- Bayer shares have lost half their value since 2018.
Companies quoted in this study
This study contains a complete overview of the companies in the market, with the latest figures and news for each company. :
Choosing this study means :
Access to more than 35 hours of work
Our studies are the result of over 35 hours of research and analysis. Using our studies allows you to devote more time and added value to your projects.
Benefit from 6 years' experience and over 1,500 industry reports already produced
Our expertise enables us to produce comprehensive studies in all sectors, including niche and emerging markets.
Our know-how and methodology enable us to produce reports that offer unique value for money.
Access to several thousand articles and paid-for data
Businesscoot has access to all the paid economic press as well as exclusive databases to carry out its market research (over 30,000 articles and private sources).
To enhance our research, our analysts also use web indicators (semrush, trends, etc.) to identify market trends and company strategies. (Consult our paying sources)
Guaranteed support after your purchase
A team dedicated to after-sales service, to guarantee you a high level of satisfaction. +44 238 097 0676
A digital format designed for our users
Not only do you have access to a PDF, but also to a digital version designed for our customers. This version gives you access to sources, data in Excel format and graphics. The content of the study can therefore be easily retrieved and adapted for your specific needs.
Our offers :
the food supplements market | Italy
- What are the figures on the size and growth of the market?
- What is driving the growth of the market and its evolution?
- What is the positioning of companies in the value chain?
- Data from several dozen databases
5 reports pack (-15%) IT Italy
- 5 reports at €75.6 excluding VAT per study to choose from our Italian catalogue for 12 months
- Save 15% on additional studies purchased
- Choose to be refunded any unused credit at the end of the 12-month period (duration of the pack)
See the terms and conditions of the pack and the refund of unused credit.
Our customer references
They have consulted our studies
Discover the opinions (+500)
Malcolm Vincent
Astoria Finance
Gregoire de Castelnau
Stags Participations
Timothé Huignard
PWC
Paul-Alexis Kebabtchieff
BCG
Aymeric Granet
Publicis Consultant
interviews & case studies
All interviews and case studies (45)
